Empowering Scientists to Accelerate Discovery
The Sapio Sessions 2025 series successfully brought together innovators, researchers, and partners shaping the future of science across five cities, from Boston to London. The central message was clear across every stop: the next era of research will be defined by connected data, AI-driven insights, and intelligent automation, all working together to help scientists focus on the work that matters most.
From Data to Decision: The U.S. Tour
The series opened in Cambridge, MA, where the conversation began with a simple but powerful question: What if scientists could move from data to decision in real time?
Regeneron’s Associate Director, Ricardo Schiavo, shared how his team is transforming discovery through data and how the Sapio Platform is helping to unify and accelerate research. He was joined by Dr. Rajesh Kumar, Senior Director of Drug Discovery at Schrödinger, who emphasized the role of digitized workflows in streamlining insights across the discovery pipeline. Dr. Kumar noted, “Sapio’s solution has allowed us to digitize critical lab functions, improve efficiency, and ensure seamless sample traceability. By unifying data and automating workflows, we’re able to focus on advancing our research with greater speed and confidence.”
The momentum then moved to San Diego, where Angela Kenyon, Director of Bioinformatics at Labcorp, revealed how digitizing workflows with the Sapio Platform helped her team cut transaction times, boost quality, and scale smarter. Martin Purschke, Head of R&D IT at EIT, added perspective on how connected ecosystems are enabling scientists to think and act with greater agility. The San Francisco session explored how AI and predictive insights are redefining the modern lab experience. Kenyon returned alongside Roi Bagsic, Head of Digital Transformation at EIT, to show how intelligent automation is empowering scientists to focus on science, not systems.
Europe’s Turn: Building the Intelligent Lab
When the series arrived in Basel, the focus shifted to global collaboration, data governance, and scalability. Stefan Schmidt, CEO of evitria AG, described how digitizing operations is driving new levels of quality and performance in biologics manufacturing. Federico Lionetti, Biomedical Software Engineer at Navignostics AG, shared how his company is redefining personalized cancer diagnostics through spatial single-cell proteomics, powered by robust digital infrastructure and AI-enabled analytics.
The finale in London showcased two leaders transforming R&D through next-generation informatics. Dr. Asvina Brown from AstraZeneca highlighted how her team is reimagining sample management to give scientists real-time visibility and control. Prashant Vaidyanathan, Director at Oxford Biomedica, showed how OXB is standardizing data and streamlining workflows across its enterprise to strengthen auditability and accelerate discovery.
A Shared Vision for Accelerated Discovery
Across all five cities, Michael Hampton, Chief Commercial Officer at Sapio Sciences, set the tone with Sapio’s vision: accelerating discovery through the fusion of AI and lab informatics. At each event, Rob Brown introduced Sapio ELaiN, the AI-powered co-scientist redefining how researchers interact with data, bringing intelligent assistance directly into the lab. The success of the Sapio Sessions 2025 series lies in the collective insights shared by the scientists, partners, and innovators who joined. Their collaboration continues to shape the future of connected, AI-powered science.
Thank You
Thank you to all the scientists, partners, and innovators who joined us across the Sapio Sessions 2025 series. Your insights and collaboration continue to shape the future of connected, AI-powered science.
See you at SapioCon 26 (https://www.sapiosciences.com/sapiocon-2026/) in Boston.